Results for "Electrocardiogram"
Conditions Encyclopedia Entry 1779319400
** **Hypertrophic Cardiomyopathy (HCM)** is a genetic disorder that affects the heart muscle, leading to thickening of the heart walls, which can impair the heart's ability to pump blood effectively. **CONTENT** ### Overview Hypertrophic Cardiomyopathy (HCM) is a complex and potentially life-threatening heart condition that affects approximately 1 in 500 people worldwide. It is characterized by the thickening of the heart muscle, particularly in the left ventricle, which can lead to impaired heart function and increased risk of sudden cardiac death. HCM is often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. The symptoms of HCM can vary widely, and many people may not experience any noticeable symptoms at all. However, common symptoms include chest pain, shortness of breath, fatigue, and dizziness. In some cases, HCM can lead to more severe complications, such as heart failure, arrhythmias, and sudden cardiac death. Early detection and treatment are crucial in managing HCM and preventing long-term complications. ### History/Background HCM was first described in the early 20th century, but it wasn't until the 1970s and 1980s that the condition gained more attention. In 1979, Dr. Barry Maron and his colleagues published a seminal paper on HCM, which helped to raise awareness of the condition and its potential risks. Since then, significant advances have been made in understanding the genetic and molecular mechanisms underlying HCM, as well as the development of new diagnostic and treatment strategies. ### Key Information HCM is caused by mutations in genes that code for proteins involved in the structure and function of the heart muscle. The most common genes associated with HCM are MYBPC3, MYH7, and TNNT2. These mutations can lead to abnormal thickening of the heart muscle, which can impair the heart's ability to pump blood effectively. Diagnosis of HCM typically involves a combination of clinical evaluation, electrocardiogram (ECG), echocardiogram, and cardiac MRI. In some cases, genetic testing may be recommended to identify the underlying genetic mutation. Treatment of HCM depends on the severity of the condition and the presence of symptoms. In mild cases, lifestyle modifications such as regular exercise and a healthy diet may be sufficient. In more severe cases, medications such as beta blockers and anti-arrhythmics may be prescribed to manage symptoms and prevent complications. In some cases, implantable cardioverter-defibrillators (ICDs) may be recommended to prevent sudden cardiac death. ### Significance HCM is a significant public health concern, particularly among young athletes and individuals with a family history of the condition. Early detection and treatment are crucial in preventing long-term complications and improving outcomes. The development of new diagnostic and treatment strategies has improved our understanding of HCM and its management. **INFOBOX** - **Name:** Hypertrophic Cardiomyopathy - **Type:** Genetic disorder - **Date:** 1979 (first described) - **Location:** Global - **Known For:** Thickening of the heart muscle, impaired heart function, and increased risk of sudden cardiac death **TAGS:** Hypertrophic Cardiomyopathy, Heart Condition, Genetic Disorder, Cardiac Disease, Sudden Cardiac Death, Heart Failure, Arrhythmias, Cardiac MRI, Echocardiogram, Electrocardiogram, Genetic Testing.
Health & MedicineConditions Encyclopedia Entry 1780290029
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle, leading to abnormal thickening of the heart walls and potentially life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1781111665
** Mitral Valve Prolapse (MVP) is a heart condition characterized by the mitral valve leaflets bulging back into the left atrium during heart contractions, leading to potential complications such as mitral regurgitation and arrhythmias. **CONTENT:** ### Overview Mitral Valve Prolapse (MVP) is a relatively common heart condition affecting the mitral valve, which separates the left atrium from the left ventricle. The mitral valve plays a crucial role in ensuring blood flows efficiently from the left atrium to the left ventricle, and then to the rest of the body. In MVP, the mitral valve leaflets bulge back into the left atrium during heart contractions, potentially leading to mitral regurgitation (leaking of blood back into the left atrium) and arrhythmias (abnormal heart rhythms). MVP can be asymptomatic or cause symptoms such as chest pain, shortness of breath, and palpitations. ### History/Background MVP has been described in medical literature since the early 20th century, with the first reported case in 1915. However, it wasn't until the 1960s that MVP gained significant attention due to the development of echocardiography, which allowed for non-invasive visualization of the heart valves. Since then, MVP has been extensively studied, and its diagnosis and treatment have evolved significantly. The American Heart Association (AHA) and other medical organizations have established guidelines for the diagnosis and management of MVP. ### Key Information **Causes and Risk Factors:** MVP can be caused by a combination of genetic and environmental factors, including: * **Genetic predisposition:** MVP can run in families, suggesting a genetic component. * **Connective tissue disorders:** Conditions such as Marfan syndrome and Ehlers-Danlos syndrome increase the risk of MVP. * **Age:** MVP is more common in young women and tends to decrease with age. * **Hormonal influences:** Hormonal fluctuations during pregnancy and menopause may contribute to MVP. **Symptoms and Diagnosis:** Symptoms of MVP can vary widely, ranging from asymptomatic to severe. Diagnosis typically involves: * **Physical examination:** A heart murmur may be detected during a physical exam. * **Echocardiography:** An ultrasound of the heart to visualize the mitral valve. * **Electrocardiogram (ECG):** To monitor heart rhythms. * **Cardiac catheterization:** To assess blood flow and pressure within the heart. ### Significance MVP can have significant implications for cardiovascular health, particularly if left untreated or poorly managed. Potential complications include: * **Mitral regurgitation:** Leaking of blood back into the left atrium, leading to increased pressure and strain on the heart. * **Arrhythmias:** Abnormal heart rhythms, which can increase the risk of stroke, heart failure, and sudden death. * **Heart failure:** MVP can lead to heart failure, characterized by the heart's inability to pump blood effectively. **INFOBOX:** - **Name:** Mitral Valve Prolapse (MVP) - **Type:** Heart condition - **Date:** First reported case in 1915 - **Location:** Affects the mitral valve, which separates the left atrium from the left ventricle - **Known For:** Characterized by mitral valve leaflets bulging back into the left atrium during heart contractions **TAGS:** Mitral Valve Prolapse, Heart Condition, Mitral Regurgitation, Arrhythmias, Heart Failure, Echocardiography, Electrocardiogram, Cardiac Catheterization, Cardiovascular Health.
Health & MedicineConditions Encyclopedia Entry 1781060525
** This entry is about **Postural Orthostatic Tachycardia Syndrome (POTS)**, a condition characterized by rapid heart rate and other symptoms that occur when a person stands upright. **CONTENT** ### Overview Postural Orthostatic Tachycardia Syndrome (POTS) is a complex condition that affects the autonomic nervous system, which regulates various bodily functions, including heart rate, blood pressure, and digestion. POTS is characterized by a rapid increase in heart rate (tachycardia) and other symptoms that occur when a person stands upright for more than 10 minutes. The symptoms can be debilitating and significantly impact a person's quality of life. POTS is often misdiagnosed or underdiagnosed, making it essential to educate healthcare professionals and the public about this condition. POTS can affect anyone, but it is more common in young women. The exact cause of POTS is unknown, but it is believed to be related to genetic, environmental, and hormonal factors. Some people with POTS may have a history of trauma, infections, or autoimmune disorders. POTS can be classified into different subtypes, including hyperadrenergic, non-hyperadrenergic, and postural orthostatic intolerance (POI). ### History/Background The concept of POTS has been around for centuries, but it was not until the 1990s that the condition gained recognition as a distinct medical entity. In 1993, the American Autonomic Society defined POTS as a condition characterized by a heart rate increase of more than 30 beats per minute within 10 minutes of standing. Since then, research has focused on understanding the pathophysiology of POTS and developing effective treatments. ### Key Information **Key Features:** - **Rapid heart rate**: A heart rate increase of more than 30 beats per minute within 10 minutes of standing. - **Orthostatic intolerance**: Symptoms worsen when standing upright and improve when lying down. - **Autonomic nervous system dysfunction**: Abnormalities in the autonomic nervous system, which regulates various bodily functions. - **Symptoms**: Headaches, dizziness, lightheadedness, nausea, fatigue, tremors, and palpitations. **Diagnosis:** - **Tilt table test**: A diagnostic test that measures heart rate and blood pressure while a person is standing upright on a tilted table. - **Electrocardiogram (ECG)**: A test that measures heart rate and rhythm. - **Blood tests**: To rule out other conditions that may cause similar symptoms. **Treatment:** - **Lifestyle modifications**: Increasing fluid and salt intake, avoiding triggers, and engaging in regular exercise. - **Medications**: Beta blockers, fludrocortisone, and midodrine to manage symptoms. - **Physical therapy**: To improve orthostatic tolerance and reduce symptoms. ### Significance POTS is a significant condition that affects millions of people worldwide. It is essential to raise awareness about POTS to ensure timely diagnosis and effective treatment. POTS can have a significant impact on a person's quality of life, affecting their ability to work, attend school, and engage in daily activities. By understanding POTS, healthcare professionals can provide better care and support for individuals with this condition. **INFOBOX:** - **Name:** Postural Orthostatic Tachycardia Syndrome (POTS) - **Type:** Autonomic nervous system disorder - **Date:** 1993 (defined as a distinct medical entity) - **Location:** Worldwide - **Known For:** Characterized by rapid heart rate and orthostatic intolerance **TAGS:** Autonomic nervous system disorder, Postural Orthostatic Tachycardia Syndrome, POTS, Orthostatic intolerance, Rapid heart rate, Tilt table test, Electrocardiogram, Blood tests, Lifestyle modifications, Medications, Physical therapy.